Citations

Clear

4207 citation(s) found for "Yu, Chen".

Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma
Wei, Xiaomu , Calvo-Vidal, M. Nieves, Chen, Siwei , Wu, Gang , Revuelta, María V. , Zhang, Jinghui , Walsh, Michael F. , Nichols, Kim E. , Vijai, Joseph , Snyder, Carrie, Vachon, Celine M. , McKay, James , Wang, Shuping , Jayabalan, David , Jacobs, Lauren , Becirovic, Dina, Waller, Rosalie G., Artomov, Mykyta , Viale, Agnès , Patel, Jayeshkumar , Curtin, Karen , Salama, Mohamed E. , Atanackovic, Djordje , Niesvizky, Rubén, Godley, Lucy A. , Churpek, Jane E. , Dumontet, Charles , Lynch, Henry T., Camp, Nicola J. , Offit, Kenneth , Klein, Robert J. , Lipkin, Steven M. , Waller, Rosalie G. , Griffin, R. L. , Joseph, Vijai , Revuelta, Maria , Waller, Rosalie G , Godley, Lucy A , Sun, Jian Hua , Vachon, Celine M. , Waller, Rosalie G., Phillip, Jude M. , Chen‐Kiang, Selina , Landgren, Ola , Slager, Susan L. , Garber, Judy E. , Anderson, Kenneth C. , Daly, Mark J. , Roeder, Robert G. , Mullighan, Charles G. , Yu, Haiyuan , Cerchietti, Leandro C. A. , Wu, Gang , Nichols, Kim E , Griffin, Rosalie , Klein, Robert , Churpek, Jane E , Churpek, Jane

Mayo Clinic

Cancer Research | March 20, 2018 | Volume: 78 | Issue: 10 | Pages: 2747-2759

10.1158/0008-5472.can-17-1900 | PMID 29559475 Get It

Abstract Given the frequent and largely incurable occurrence of multiple myeloma, identification of germline genetic mutations that predispose cells to multiple myeloma may provide insight into disease etiology and the developmental mechanisms of its cell of origin, the plasma cell (PC). Here, we identified familial and early-onset multiple myeloma kindreds with truncating mutations in lysine-specific demethylase 1 (LSD1/KDM1A), an epigenetic transcriptional repressor that primarily demethylates histone H3 on lysine 4 and regulates hematopoietic stem cell self-renewal. In addition, we found higher rates of germline truncating and predicted deleterious missense KDM1A mutations in patients with multiple myeloma unselected for family history compared with controls. Both monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma cells have significantly lower KDM1A transcript levels compared with normal PCs. Transcriptome analysis of multiple myeloma cells from KDM1A mutation carriers shows enrichment of pathways and MYC target genes previously associated with myeloma pathogenesis. In mice, antigen challenge followed by pharmacologic inhibition of KDM1A promoted PC expansion, enhanced secondary immune response, elicited appearance of serum paraprotein, and mediated upregulation of MYC transcriptional targets. These changes are consistent with the development of MGUS. Collectively, our findings show that KDM1A is the first autosomal-dominant multiple myeloma germline predisposition gene providing new insights into its mechanistic roles as a tumor suppressor during post-germinal center B-cell differentiation. Significance: KDM1A is the first germline autosomal dominant predisposition gene identified in multiple myeloma and provides new insights into multiple myeloma etiology and the mechanistic role of KDM1A as a tumor suppressor during post-germinal center B-cell differentiation. Cancer Res; 78(10); 2747–59. ©2018 AACR.
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
Major-Monfried, Hannah , Renteria, Anne S. , Pawarode, Attaphol , Reddy, Pavan , Ayuk, Francis , Holler, Ernst , Efebera, Yvonne A. , Wölfl, Matthias , Wudhikarn, Kitsada , Ordemann, Rainer, Young, Rachel , Hartwell, Matthew J. , Chaudhry, Mohammed S., Aziz, Mina, Etra, Aaron , Yanik, Gregory A. , Kröger, Nicolaus , Weber, Daniela , Chen, Yi‐Bin , Nakamura, Ryotaro , Rösler, Wolf, Kitko, Carrie L. , Harris, Andrew C. , Kowalyk, Steven, Morales, George , Torres, I.M., Özbek, Umut , Ferrara, James L.M. , Levine, John E. , Kroger, Nicolaus , Kroger, Nicolaus , Levine, John E , Hogan, William J. , Qayed, Muna , Hexner, Elizabeth O. , Shah, Jay Narayan , Pulsipher, Michael A. , Reshef, Ran , Kröger, Nicolaus

Mayo Clinic

Blood | March 15, 2018 | Volume: 131 | Issue: 25 | Pages: 2846-2855

10.1182/blood-2018-01-822957 | PMID 29545329 Get It

Key Points Biomarker scores generated after 1 week of steroid treatment of GVHD are prognostic. Biomarkers reflect prognosis better than early clinical response to GVHD treatment.
Clinical acceptance testing and scanner comparison of ultrasound shear wave elastography
Long, Zaiyang , Tradup, Donald J., Stekel, Scott F. , Chen, Shigao , Glazebrook, Katrina N. , Hangiandreou, Nicholas J., Song, Pengfei

Mayo Clinic

Journal of Applied Clinical Medical Physics | March 15, 2018 | Volume: 19 | Issue: 3 | Pages: 336-342

10.1002/acm2.12310 | PMID 29542277 Get It

AbstractBecause of the rapidly growing use of ultrasound shear wave elastography (SWE) in clinical practices, there is a significant need for development of clinical physics performance assessment methods for this technology. This study aims to report two clinical medical physicists’ tasks: (a) acceptance testing (AT) of SWE function on ten commercial ultrasound systems for clinical liver application and (b) comparison of SWE measurements of targets across vendors for clinical musculoskeletal application. For AT, ten GE LOGIQ E9 XDclear 2.0 scanners with ten C1‐6‐D and ten 9L‐D transducers were studied using two commercial homogenous phantoms. Five measurements were acquired at two depths for each scanner/transducer pair by two operators. Additional tests were performed to access effects of different coupling media, phantom locations and operators. System deviations were less than 5% of group mean or three times standard deviation; therefore, all systems passed AT. A test protocol was provided based on results that no statistically significant difference was observed between using ultrasound gel and salt water for coupling, among different phantom locations, and that interoperator and intraoperator coefficient of variation was less than 3%. For SWE target measurements, two systems were compared — a Supersonic Aixplorer scanner with a SL10‐2 and a SL15‐4 transducer, and an abovementioned GE scanner with 9L‐D transducer. Two stepped cylinders with diameters of 4.05–10.40 mm were measured both longitudinally and transaxially. Target shear wave speed quantification was performed using an in‐house MATLAB program. Using the target shear wave speed deduced from phantom specs as a reference, SL15‐4 performed the best at the measured depth. However, it was challenging to reliably measure a 4.05 mm target for either system. The reported test methods and results could provide important information when dealing with SWE‐related tasks in the clinical environment.
A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia
Chen, Xu , Gustafsson, Stefan , Whitington, Thomas, Borné, Yan , Lorentzen, Erik , Sun, Jitong , Almgren, Peter , Su, Jun , Lu, Yi , Zhan, Yiqiang , Hägg, Sara , Svensson, Per , Smedby, Karin E. , Lindgren, Cecilia M. , Morris, Andrew P. , Melander, Olle , Karlsson, Thomas , Fairé, Ulf dé , Lind, Lars , Pedersen, Nancy L. , Magnusson, Patrik K. E. , Lu, Yi , Karlsson, Robert , Song, Jie , Slager, Susan L. , Ingelsson, Erik , Caidahl, Kenneth , Engström, Gunnar , Karlsson, Mikael C. I. , Frostegård, Johan

Mayo Clinic

Human Molecular Genetics | March 14, 2018 | Volume: 27 | Issue: 10 | Pages: 1809-1818

10.1093/hmg/ddy094 | PMID 29547969 Get It

Systematic Bias Introduced by Genomic DNA Template Dilution in 16S rRNA Gene-Targeted Microbiota Profiling in Human Stool Homogenates
Harrington, Sean C., Jeraldo, Patricio , Johnson, Stephen , Walther-António, Marina , Multinu, Francesco , Jeraldo, Patricio R , Chia, Nicholas , Walther-Antonio, Marina R, Walther-Antonio, Marina , Chen, Jun, Chia, Nicholas

Mayo Clinic

mSphere | March 13, 2018 | Volume: 3 | Issue: 2 | Pages: No page available

10.1128/msphere.00560-17 | PMID 29564398 Get It

The genomic DNA input for stool samples utilized for microbiome composition has not been determined. In this study, we determined the reliable threshold level under which conclusions drawn from the data may be compromised. We also determined the type of microbial bias introduced by less-than-ideal genomic input.
Predicted Arabidopsis Interactome Resource and Gene Set Linkage Analysis: A Transcriptomic Analysis Resource
Yao, Heng , Wang, Xiaoxuan , Chen, Pengcheng , Jin, Kang , Yao, Lixia , Mao, Chuanzao , Chen, Xin , Jin, Kang , Yao, Lixia , Mao, Chuanzao , Chen, Xin , Hai, Ling

Mayo Clinic

Plant Physiology | March 12, 2018 | Volume: 177 | Issue: 1 | Pages: 422-433

10.1104/pp.18.00144 | PMID 29530937 Get It

Complex electrophysiological remodeling in postinfarction ischemic heart failure
Hegyi, Bence , Bossuyt, Julie , Griffiths, Leigh G. , Shimkunas, Rafael, Coulibaly, Zana, Jian, Zhong , Grimsrud, Kristin, Søndergaard, Claus S., Ginsburg, Kenneth S., Chiamvimonvat, Nipavan , Belardinelli, Luiz, Varró, András , Papp, Julius Gy., Pollesello, Piero , Levijoki, Jouko , Izu, Leighton T. , Boyd, W. Douglas, Bers, Donald M. , Chen‐Izu, Ye , Griffiths, Leigh G , Bányász, Tamás

Mayo Clinic

Proceedings of the National Academy of Sciences | March 12, 2018 | Volume: 115 | Issue: 13 | Pages: No page available

10.1073/pnas.1718211115 | PMID 29531045 Get It

Significance Cardiac arrhythmias often occur in heart failure (HF) patients, but drug therapies using selective ion channel blockers have failed clinical trials and effective drug therapies remain elusive. Here we systematically study the major ionic currents during the cardiac action potential (AP) and arrhythmogenic Ca 2+ release in postinfarction HF. We found that changes in any individual current are relatively small, and alone could mislead as to consequences. However, differential changes in multiple currents integrate to shorten AP in the infarct border zone but prolong AP in the remote zone, increasing AP repolarization inhomogeneity. Our findings help explain why single channel-blocker therapy may fail, and highlight the need to understand the integrated changes of ionic currents in treating arrhythmias in HF.
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
Claxton, J’Neka S. , MacLehose, Richard F. , Chen, Lin Y. , Bengtson, Lindsay G.S. , Chamberlain, Alanna M. , Norby, Faye L. , Lutsey, Pamela L. , Chamberlain, Alanna M , Chen, Lin Y , Lutsey, Pamela L , O’Neal, Wesley T. , Sandesara, Pratik B. , Alonso, Álvaro

Mayo Clinic

Journal of the American Heart Association | March 11, 2018 | Volume: 7 | Issue: 6 | Pages: No page available

10.1161/jaha.117.007943 | PMID 29525778 Get It

Background Differences in anticoagulation rates and direct oral anticoagulant use by provider specialty may identify an area of practice improvement to reduce future stroke events in patients with atrial fibrillation ( AF ). Methods and Results We examined anticoagulant prescription fills in 388 045 (mean age, 68±15 years; 59% male) patients with incident AF from the MarketScan databases between 2009 and 2014. Provider specialty and filled anticoagulant prescriptions around the time of AF diagnosis (3 months before through 6 months after) were obtained from outpatient services and pharmacy claims. We estimated the association of provider specialty (cardiology versus primary care) with filling oral anticoagulant prescriptions, adjusting for patient characteristics. The risk of stroke and bleeding events also was explored. A total of 235 739 patients (61%) had a cardiology provider claim, whereas 152 306 (39%) were exclusively managed by primary care. Patients seen by cardiology providers were more likely to fill anticoagulant prescriptions than those seen by primary care (39% versus 27%; relative risk, 1.39; 95% confidence interval [ CI ], 1.37–1.40). Differences were observed for direct oral anticoagulants (relative risk, 1.74; 95% CI , 1.71–1.78) and warfarin (relative risk, 1.24; 95% CI , 1.22–1.26). A reduced risk of stroke events was observed among those seen by cardiology providers (hazard ratio, 0.90; 95% CI , 0.86–0.94) compared with primary care, without an increased bleeding risk (hazard ratio, 1.03; 95% CI , 0.98–1.07). Conclusions Patients seen by an outpatient cardiology provider shortly after AF diagnosis were more likely to initiate oral anticoagulation and were at lower risk of future stroke events without a higher rate of bleeding. Early referral to cardiology specialists may increase initiation of anticoagulant therapies and improve outcomes in AF .
GMPR: A robust normalization method for zero-inflated count data with application to microbiome sequencing data
Reeve, James , Zhang, L. , Huang, Shengbing, Wang, Xuefeng , Chen, Li , Chen, Jun

Mayo Clinic

No container title available | March 7, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7287/peerj.preprints.3417v3 Get It

Normalization is the first critical step in microbiome sequencing data analysis used to account for variable library sizes. Current RNA-Seq based normalization methods that have been adapted for microbiome data fail to consider the unique characteristics of microbiome data, which contain a vast number of zeros due to the physical absence or under-sampling of the microbes. Normalization methods that specifically address the zero inflation remain largely undeveloped. Here we propose GMPR - a simple but effective normalization method - for zero-inflated sequencing data such as microbiome data. Simulation studies and real datasets analyses demonstrate that the proposed method is more robust than competing methods, leading to more powerful detection of differentially abundant taxa and higher reproducibility of the relative abundances of taxa.
Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital ( SEARCH ) database
Herforth, Christine, Stroup, Sean P. , Chen, Zinan, Howard, Lauren E. , Freedland, Stephen J. , Amling, Christopher L. , Moreira, Daniel M. , Terris, Martha K. , Aronson, William J. , Cooperberg, Matthew R , Kane, Christopher J. , Howard, Lauren E , Stroup, Sean P

Mayo Clinic

BJU International | February 23, 2018 | Volume: 122 | Issue: 4 | Pages: 592-598

10.1111/bju.14178 | PMID 29473992 Get It

Objective To evaluate biochemical recurrence ( BCR ) patterns amongst men undergoing radical prostatectomy ( RP ) with specimens having negative ( NSM ), positive ( PSM ), and close surgical margins ( CSM ) from the Shared Equal Access Regional Cancer Hospital ( SEARCH ) cohort, as PSM after RP are a significant predictor of biochemical failure and possible disease progression, with CSM representing a diagnostic challenge for surgeons. Patients and Methods Men undergoing RP between 1988 and 2015 with known final pathological margin status were evaluated. The cohort was divided into three groups based on margin status; NSM , PSM , and CSM . CSM were defined by distance of tumour ≤1 mm from the surgical margin. BCR was defined as a prostate‐specific antigen ( PSA ) level of >0.2 ng/mL, two values at 0.2 ng/mL, or secondary treatment for an elevated PSA level. Predictors of BCR , metastases, and mortality were analysed using Cox proportional hazard models. Results Of 5515 men in the SEARCH database, 4337 (79%) men met criteria for inclusion in the analysis. Of these, 2063 (48%) had NSM , 1902 (44%) had PSM , and 372 (8%) had CSM . On multivariable analysis, relative to NSM , men with CSM had a higher risk of BCR (hazard ratio [ HR ] 1.51, 95% confidence interval [ CI ] 1.25–1.82; P < 0.001) but a decreased risk of BCR when compared to those men with PSM ( HR 2.09, 95% CI 1.86–2.36; P < 0.001). Metastases, prostate cancer‐specific mortality and all‐cause mortality did not differ based on margin status alone. Conclusions Management of men with CSM is a diagnostic challenge, with a disease course that is not entirely benign. The evaluation of other known risk factors probably provides greater prognostic value for these men and may ultimately better select those who may benefit from adjuvant therapy.